The 23rd Congress of the European Society for Therapeutic Radiology and Oncolo...( From 24-28 October 2004 the 23rd Intern...),Health

From 24-28 October 2004 the 23rd International Congress of the European Society for Therapeutic Radiology and Oncology (ESTRO) will be held in the RAI Congress Centre in Amsterdam, The Netherlands. More than 3,000 participants from around the world are expected to attend this bi-annual meeting of the ESTRO.

It is our pleasure to invite you to attend the official Press Conference at 12:30CET on Tuesday 26 October. The Press Conference will take place in the "L Room" in the conference centre of the RAI.

Press Conference: New findings in prostate, breast and head and neck cancer:

Professor Michael Brada and Professor Harry Bartelink will, together with other European radiotherapy experts, present a summary of the latest developments and research results in the field of radiotherapy. The focus will be on the increase in cure rates with reduced side effects for a range of tumour types.

The Press Conference will include presentations of:

• A breast cancer study of more than 5,000 patients, which showed that a more precise and higher treatment dose decreases, by approximately 20%, the chance of breast cancer returning in women who have undergone breast saving treatment. A very high survival rate of 85% after 8 years is demonstrated.

• New results that will dramatically improve the treatment of prostate cancer. The results of a major European trial demonstrate that radiotherapy given after surgical removal of the prostate substantially improves survival will be presented.

• The remarkable results from a European-American study in patients with head and neck cancer. A new drug, Cetuximab (an antibody against a receptor on cell membranes), when given concomitantly with radiotherapy leads to a 13% higher survival rate after 3 years. With this trial the proof of principle is established and demonstrates that the use of "smart drugs" will lead to improvements in cure rates. The design of such smart drugs is bas
  '"/>

Contact: Muriel Hallet
muriel.hallet@estro.be
32-486-505-860
Federation of European Cancer Societies
20-Oct-2004


Page: 1 2
Related medicine news :

1. Advances in Uterine Leiomyoma Research: 2nd NIH International Congress
2. ESMO and Imedex announce partnership for the World Congress on Gastrointestinal Cancer
3. Alliance congratulates Congress and NIH
4. National survey shows few physicians elected to Congress
5. Congress of Neuological Surgeons meets in San Francisco
6. Media invitation - European Society of Cardiology Congress 2004
7. News from the 11th Congress of the International Psychogeriatric Association
8. Many low income Medicare beneficiaries will still face high drug bills under proposals in Congress
9. Report urges Congress to increase medical research
10. NPSF Patient Safety Congress looks at safety from nine points of view
11. Bridge Medical joins NPSF and 34 organizations in convening historic Congress